<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0186-2391</journal-id>
<journal-title><![CDATA[Acta pediátrica de México]]></journal-title>
<abbrev-journal-title><![CDATA[Acta pediatr. Méx]]></abbrev-journal-title>
<issn>0186-2391</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0186-23912016000500260</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Beneficios de la suplementación con L-carnitina en pacientes pediátricos hemodializados. Reporte de casos]]></article-title>
<article-title xml:lang="en"><![CDATA[Benefits of L-carnitine supplementation in pediatric hemodialysis patients: Cases report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Morales]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Raya-Jiménez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Monroy-Torres]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Daza-Benítez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Guanajuato Campus León ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,UMAE Hospital Gineco/pediatría No.48 Unidad Médica de Alta Especialidad ]]></institution>
<addr-line><![CDATA[León Guanajuato]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>37</volume>
<numero>5</numero>
<fpage>260</fpage>
<lpage>270</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0186-23912016000500260&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0186-23912016000500260&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0186-23912016000500260&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  INTRODUCCIÓN la mayoría de los pacientes pediátricos con insuficiente renal crónica desarrollan desnutrición y anemia. Para tratar esta última se administra eritropoyetina como tratamiento de elección, pero no se logra recuperar la situación nutricional del paciente, por lo que la L-carnitina es una alternativa que mejora el estado nutricional y, al mismo tiempo, disminuye la frecuencia de anemia.  OBJETIVO mejorar los parámetros bioquímicos y antropométricos después de la suplementación con L-carnitina en pacientes pediátricos.  MATERIAL Y MÉTODOS se realizó un estudio analítico y longitudinal, de una serie de casos en 25 participantes, ambos sexos, de 3 a 16 años de edad, con insuficiencia renal crónica y en tratamiento de hemodiálisis. Se les suministró L-carnitina por vía intravenosa (50 mg/ kg/sesión) 30 minutos antes de terminar las sesiones de hemodiálisis, durante tres meses (36 sesiones). Antes y después de la maniobra se compararon algunos indicadores bioquímicos (hemoglobina, albumina, colesterol, triglicéridos, creatinina) y antropométricos. Se realizó una comparación con T de Student y por proporciones (casos que mejoraron después de maniobra y la reducción del riesgo absoluto).  RESULTADOS la edad promedio de los casos fue 12.4 años (rango de 3 a 16 años). Al comparar los casos con T de Student se obtuvo una mejora significativa con la suplementación para el peso seco (p=0.004); índice de masa corporal (p=0.04); albúmina (p=0.02) y colesterol (p=0.003). Con el cálculo por proporciones de los casos que mejoraron con la maniobra se observó la reducción del riesgo atribuible en un rango de 12 a 68% de todas las variables de interés (hemoglobina, albúmina, colesterol, triglicéridos, peso seco e índice de masa corporal).  CONCLUSIONES la suplementación con L-carnitina intravenosa (50 mg/kg/sesión) 30 minutos antes de terminar cada sesión de hemodiálisis, durante tres meses, permitió una mejora en el porcentaje de los casos de estudio para peso seco, índice de masa corporal, albúmina, hemoglobina, colesterol y triglicéridos, con una reducción del riesgo atribuible de 12 a 68% de los casos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  INTRODUCTION Most pediatric patients with chronic renal failure develop mal nutrition and anemia. To treat anemia, erythropoietin (EPO) is administered as a treatment of choice, but does not recover the nutritional status of the patient, so that L-carnitine, is presented as an alternative that improves the nutritional status, while It decreases the frequency of anemia.  OBJECTIVE To improve the biochemical and anthropometric parameters, after supplementation with L-carnitine in pediatric patients.  MATERIAL AND METHODS A longitudinal study, case series in 25 participants, both sexes, aged 3-16 years old, with chronic renal failure and hemodialysis was performed. They were provided L-carnitine i.v. (50 mg / kg / session), 30 minutes before finishing hemodialysis sessions for three months (36 sessions). Before and after the maneuver some biochemical parameters (hemoglobin, albumin, cholesterol, triglycerides, creatinine) and anthropometric were compared. a comparison with T Student and proportions (cases improved after switching and absolute risk reduction) was performed mainly.  RESULTS The average age of cases was 12.4 years (range 3-16 years). When comparing cases with T student, a significant improvement with supplementation for dry weight (p = 0.004), body mass index (p = 0.04), albumin (p = 0.02) and cholesterol (p = 0.003) was obtained. With the calculation proportions of cases improved with the maneuver, reducing the risk attributable observed in a range from 12 to 68% of all of the variables of interest (hemoglobin, albumin, cholesterol, triglycerides, dry weight and BMI).  CONCLUSIONS Supplementation connote-carnitine I.V. 50 mg / kg / session, 30 minutes before the end of each hemodialysis session for three months, allowed an improvement in the percentage of case studies for dry weight, BMI, albumin, hemoglobin, cholesterol and triglycerides, a reduction attributable risk of 12 to 68% of cases.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[insuficiencia renal crónica]]></kwd>
<kwd lng="es"><![CDATA[anemia]]></kwd>
<kwd lng="es"><![CDATA[suplementación]]></kwd>
<kwd lng="es"><![CDATA[L-carnitina]]></kwd>
<kwd lng="en"><![CDATA[chronic renal failure]]></kwd>
<kwd lng="en"><![CDATA[anemia]]></kwd>
<kwd lng="en"><![CDATA[supplementation]]></kwd>
<kwd lng="en"><![CDATA[Lcarnitine]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Características epidemiológicas de la insuficiencia renal crónica (IRC) en Pediatría]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Troche]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ávalos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zarza de Bolaños]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Parag Pediatr.]]></source>
<year>2005</year>
<numero>32</numero>
<issue>32</issue>
<page-range>122-39</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[GT]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desnutrición energético-proteínica.]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Casanueva]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kaufere]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Arroyo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutriología Médica]]></source>
<year>2008</year>
<edition>3a</edition>
<page-range>263-95</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Médica Panamericana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Anemia in children with chronic kidney disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Susan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Geary]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2008</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>209-19</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[L carnitine in hemodialysis patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caló]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Vertolli]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Savica]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Hemodial Int.]]></source>
<year>2012</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>428-34</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hemodialysis in children: general practical guidelines]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fischbach]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Edefonti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Schroder]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<collab>The European Pediatric Dialysis Working Group</collab>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2005</year>
<volume>20</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1054-66</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="">
<collab>National Center for Toxicological Research</collab>
<source><![CDATA[Annual. Report]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="">
<collab>COFEPRIS</collab>
<source><![CDATA[Relación de certificados de libre venta emitidos durante el 2do semestre del 2011]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of L-Carnitine Supplementation in Maintenance Hemodialysis Patients: A Systematic Review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hurot]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Cucherat]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Haugh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fouque]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[J Am Soc Nephrol.]]></source>
<year>2002</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>708-14</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis Patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Matsura]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hatakeyama]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[koni]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mabuchi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Muramoto]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[J Nephrol.]]></source>
<year>2008</year>
<volume>72</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kathleen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Escott]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapia nutricional médica en trastornos renales]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Wilkens]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Juneja]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Krause Dietoterapia]]></source>
<year>2009</year>
<edition>12th</edition>
<page-range>921-59</page-range><publisher-loc><![CDATA[Barcelona, España ]]></publisher-loc>
<publisher-name><![CDATA[MASSON]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The role of oral L-Carnitine therapy in chronic hemodialysis patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sabry]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<source><![CDATA[Saudi J kidney Dis transpl.]]></source>
<year>2010</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>454-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ávila]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Caraveo]]></surname>
<given-names><![CDATA[VE]]></given-names>
</name>
<name>
<surname><![CDATA[Valcez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tejero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación del estado de nutrición]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Casanueva]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kaufere]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Arroyo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutriología Médica]]></source>
<year>2008</year>
<edition>3a</edition>
<page-range>747-83</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Médica Panamericana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[L-carnitine supplementation and EPO requirement in children on chronic hemodialysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aoun]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Berard]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vitkevic]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dehée]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bensman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ulinski]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2010</year>
<volume>25</volume>
<page-range>557-60</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lilien]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Duran]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quak]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Frankhuisen]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Schröder]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2000</year>
<volume>15</volume>
<page-range>17-20</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effect of L-carnitine supplementation on red blood cell deformability in hemodialysis patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nikolaos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[George]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Telemachos]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Maria]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yannis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Konstantinos]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ren Fail]]></source>
<year>2000</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>73-80</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Methods for assessing nutritional status of patients with renal failure]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blumenkrantz]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kopple]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Gutman]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
<name>
<surname><![CDATA[Barbour]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Clin Nutr]]></source>
<year>1980</year>
<volume>33</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1567-85</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The effect of oral L-carnitine supplementation on the lipid profiles of hyperlipidaemic in children]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Günes]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Yalcin]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[kalkanoglu]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Onol]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dursun]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cos&#807;kun]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Acta Paediatrica]]></source>
<year>2005</year>
<volume>94</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>711-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
